The radiopharmaceutical consists of a radioactive molecule – in this case terbium-161 linked to a ligand. This ligand recognises proteins on the tumour cell, allowing highly targeted cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback